In one of the largest studies of its kind, a trial of Boston Scientific’s small, permanent cardiac implant showed that it could potentially serve as an alternative to long-term blood thin | Boston ...
The company said it will seek an expanded indication for the left atrial appendage closure device after it met all safety and ...
Investor's Business Daily on MSN
Boston Scientific just took a 9% header. Why analysts are still bullish
Boston Scientific stock tumbled Monday on mixed test results for its Watchman device in patients at risk of having a stroke.
A new Watchman device at McLaren Port Huron offers eligible AFib patients an alternative to long‑term blood thinners to help ...
CHAMPION-AF shows Boston Scientific's Watchman FLX as a safe, effective first-line option for stroke risk reduction in ...
Boston Scientific (NYSE:BSX) announced new findings from the CHAMPION-AF trial supporting its Watchman FLX system.
When David Reed was first diagnosed with atrial fibrillation (AFib), the treatment felt more unsettling than the disease. The most common form of heart arrhythmia, AFib prompts the heart’s upper ...
A left atrial appendage closure is a procedure your doctor may recommend if: you have atrial fibrillation (also known as AF or AFib) or you are not a good candidate for taking blood thinner medication ...
AFib is a common heart rhythm disorder consisting of rapid and irregular heartbeats, which can lead to the formation of blood clots in the heart. These clots develop in a small pouch called the left ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results